NCT02366130 2021-10-07Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast CancerM.D. Anderson Cancer CenterPhase 2 Completed45 enrolled 7 charts